Nova Eye Medical Limited (ASX:EYE)
0.1300
+0.0100 (8.33%)
May 9, 2025, 4:10 PM AEST
Nova Eye Medical Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2015 - 2019 |
Cash & Equivalents | 2.26 | 6.15 | 7.42 | 8 | 17.8 | 95.65 | Upgrade
|
Cash & Short-Term Investments | 2.26 | 6.15 | 7.42 | 8 | 17.8 | 95.65 | Upgrade
|
Cash Growth | -13.55% | -17.09% | -7.26% | -55.06% | -81.39% | 522.23% | Upgrade
|
Accounts Receivable | 3.09 | 3.9 | 1.93 | 2.05 | 1.91 | 1.69 | Upgrade
|
Other Receivables | - | 0.18 | 1.18 | 1.72 | 3.52 | 2.14 | Upgrade
|
Receivables | 3.09 | 4.08 | 3.11 | 3.77 | 5.43 | 3.83 | Upgrade
|
Inventory | 4.36 | 4.28 | 3.81 | 3.54 | 2.9 | 2.93 | Upgrade
|
Prepaid Expenses | 0.31 | 0.23 | 0.27 | 0.28 | 0.2 | 0.49 | Upgrade
|
Total Current Assets | 10.02 | 14.75 | 14.6 | 15.59 | 26.33 | 102.91 | Upgrade
|
Property, Plant & Equipment | 3.72 | 3.9 | 2.36 | 2.95 | 3.51 | 2.91 | Upgrade
|
Other Intangible Assets | 7.5 | 7.03 | 8.45 | 7.17 | 3.44 | 3.34 | Upgrade
|
Long-Term Deferred Charges | 4.35 | 4.13 | 4.87 | 10.85 | 8.66 | 7.54 | Upgrade
|
Other Long-Term Assets | 0.07 | 0.07 | 0.07 | 0.07 | 0.06 | 0.05 | Upgrade
|
Total Assets | 25.66 | 29.88 | 30.36 | 36.63 | 41.99 | 116.74 | Upgrade
|
Accounts Payable | 2.86 | 3.57 | 4.31 | 2.41 | 2 | 3.83 | Upgrade
|
Accrued Expenses | - | 1.64 | 1.32 | 0.91 | 0.74 | 0.46 | Upgrade
|
Current Portion of Long-Term Debt | - | - | - | - | 1.42 | 1.55 | Upgrade
|
Current Portion of Leases | 0.55 | 0.48 | 0.64 | 0.54 | 0.52 | 0.36 | Upgrade
|
Current Income Taxes Payable | - | - | - | - | - | 8.15 | Upgrade
|
Other Current Liabilities | 2.05 | - | 0.01 | 0.01 | 0 | 0.01 | Upgrade
|
Total Current Liabilities | 5.46 | 5.68 | 6.27 | 3.86 | 4.69 | 14.36 | Upgrade
|
Long-Term Leases | 2.83 | 2.87 | 0.89 | 1.4 | 1.76 | 1.43 | Upgrade
|
Long-Term Deferred Tax Liabilities | - | - | - | 0.97 | 0.14 | 0.32 | Upgrade
|
Other Long-Term Liabilities | - | - | - | - | 0.08 | 0.05 | Upgrade
|
Total Liabilities | 8.29 | 8.55 | 7.17 | 6.23 | 6.66 | 16.16 | Upgrade
|
Common Stock | 52.73 | 52.71 | 45.18 | 37.44 | 36.68 | 78.31 | Upgrade
|
Retained Earnings | -36.08 | -30.69 | -21.9 | -6.6 | 0.89 | 24.63 | Upgrade
|
Comprehensive Income & Other | 0.72 | -0.69 | -0.09 | -0.44 | -2.24 | -2.36 | Upgrade
|
Shareholders' Equity | 17.38 | 21.33 | 23.19 | 30.4 | 35.34 | 100.59 | Upgrade
|
Total Liabilities & Equity | 25.66 | 29.88 | 30.36 | 36.63 | 41.99 | 116.74 | Upgrade
|
Total Debt | 3.38 | 3.35 | 1.53 | 1.94 | 3.7 | 3.34 | Upgrade
|
Net Cash (Debt) | -1.12 | 2.8 | 5.89 | 6.06 | 14.1 | 92.31 | Upgrade
|
Net Cash Growth | - | -52.41% | -2.79% | -57.05% | -84.72% | 31620.62% | Upgrade
|
Net Cash Per Share | -0.01 | 0.01 | 0.04 | 0.04 | 0.10 | 0.64 | Upgrade
|
Filing Date Shares Outstanding | 229.53 | 229.06 | 190.33 | 145.58 | 143.69 | 143.6 | Upgrade
|
Total Common Shares Outstanding | 229.53 | 228.82 | 190.33 | 145.58 | 143.69 | 143.6 | Upgrade
|
Working Capital | 4.56 | 9.07 | 8.33 | 11.73 | 21.64 | 88.55 | Upgrade
|
Book Value Per Share | 0.08 | 0.09 | 0.12 | 0.21 | 0.25 | 0.70 | Upgrade
|
Tangible Book Value | 9.88 | 14.3 | 14.74 | 23.22 | 31.89 | 97.25 | Upgrade
|
Tangible Book Value Per Share | 0.04 | 0.06 | 0.08 | 0.16 | 0.22 | 0.68 | Upgrade
|
Machinery | - | 3.07 | 2.96 | 2.56 | 2.32 | 1.96 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.